Ewing C I, Gibbs A C, Ashcroft C, David T J
Department of Child Health, University of Manchester, U.K.
Eur J Clin Nutr. 1991 Oct;45(10):507-10.
An eight week double-blind placebo-controlled trial of oral zinc sulphate 185.4 mg per day was undertaken in 50 children with atopic eczema aged 1-16 years. In those receiving zinc there was no significant improvement in disease severity as assessed by surface area affected and degree of erythema, symptom scores of itch, sleep disturbance and redness of skin, or weight of emollient or topical steroid use.
对50名年龄在1至16岁的特应性皮炎患儿进行了一项为期8周的双盲安慰剂对照试验，试验中患儿每天口服185.4毫克硫酸锌。在接受锌治疗的患儿中，根据受影响的表面积、红斑程度、瘙痒症状评分、睡眠障碍和皮肤发红情况，以及润肤剂或局部类固醇的使用量来评估，疾病严重程度没有显著改善。
